225 related articles for article (PubMed ID: 22196450)
21. Association of the SLC22A1, SLC22A2, and SLC22A3 genes encoding organic cation transporters with diabetic nephropathy and hypertension.
Sallinen R; Kaunisto MA; Forsblom C; Thomas M; Fagerudd J; Pettersson-Fernholm K; Groop PH; Wessman M;
Ann Med; 2010 May; 42(4):296-304. PubMed ID: 20429798
[TBL] [Abstract][Full Text] [Related]
22. Proton pump inhibitors inhibit metformin uptake by organic cation transporters (OCTs).
Nies AT; Hofmann U; Resch C; Schaeffeler E; Rius M; Schwab M
PLoS One; 2011; 6(7):e22163. PubMed ID: 21779389
[TBL] [Abstract][Full Text] [Related]
23. Organic cation transporters OCT1, 2, and 3 mediate high-affinity transport of the mutagenic vital dye ethidium in the kidney proximal tubule.
Lee WK; Reichold M; Edemir B; Ciarimboli G; Warth R; Koepsell H; Thévenod F
Am J Physiol Renal Physiol; 2009 Jun; 296(6):F1504-13. PubMed ID: 19357179
[TBL] [Abstract][Full Text] [Related]
24. Organic cation transporters (OCTs, MATEs), in vitro and in vivo evidence for the importance in drug therapy.
Nies AT; Koepsell H; Damme K; Schwab M
Handb Exp Pharmacol; 2011; (201):105-67. PubMed ID: 21103969
[TBL] [Abstract][Full Text] [Related]
25. Organic Cation Transporters (OCTs) in EpiAirway™, A Cellular Model of Normal Human Bronchial Epithelium.
Barilli A; Visigalli R; Ferrari F; Di Lascia M; Riccardi B; Puccini P; Dall'Asta V; Rotoli BM
Biomedicines; 2020 May; 8(5):. PubMed ID: 32438722
[TBL] [Abstract][Full Text] [Related]
26. Clinicopathological significance of RASSF1A reduced expression and hypermethylation in hepatocellular carcinoma.
Hu L; Chen G; Yu H; Qiu X
Hepatol Int; 2010 Jan; 4(1):423-32. PubMed ID: 20305761
[TBL] [Abstract][Full Text] [Related]
27. Kidney-specific expression of human organic cation transporter 2 (OCT2/SLC22A2) is regulated by DNA methylation.
Aoki M; Terada T; Kajiwara M; Ogasawara K; Ikai I; Ogawa O; Katsura T; Inui K
Am J Physiol Renal Physiol; 2008 Jul; 295(1):F165-70. PubMed ID: 18508876
[TBL] [Abstract][Full Text] [Related]
28. Organic cation transporters: physiology, toxicology and special focus on ethidium as a novel substrate.
Lee WK; Wolff NA; Thévenod F
Curr Drug Metab; 2009 Jul; 10(6):617-31. PubMed ID: 19702534
[TBL] [Abstract][Full Text] [Related]
29. Expression of organic cation transporter 1 (OCT1): unique patterns of indirect regulation by nuclear receptors and hepatospecific gene regulation.
Hyrsova L; Smutny T; Trejtnar F; Pavek P
Drug Metab Rev; 2016 May; 48(2):139-58. PubMed ID: 27278216
[TBL] [Abstract][Full Text] [Related]
30. The lack of the organic cation transporter OCT1 at the plasma membrane of tumor cells precludes a positive response to sorafenib in patients with hepatocellular carcinoma.
Geier A; Macias RI; Bettinger D; Weiss J; Bantel H; Jahn D; Al-Abdulla R; Marin JJ
Oncotarget; 2017 Feb; 8(9):15846-15857. PubMed ID: 28178663
[TBL] [Abstract][Full Text] [Related]
31. Identification of intragenic methylation in the TUSC1 gene as a novel prognostic marker of hepatocellular carcinoma.
Shimizu D; Kanda M; Nomoto S; Oya H; Takami H; Hibino S; Suenaga M; Inokawa Y; Hishida M; Takano N; Nishikawa Y; Yamada S; Fujii T; Nakayama G; Sugimoto H; Koike M; Fujiwara M; Kodera Y
Oncol Rep; 2014 Mar; 31(3):1305-13. PubMed ID: 24366000
[TBL] [Abstract][Full Text] [Related]
32. Update on drug-drug interaction at organic cation transporters: mechanisms, clinical impact, and proposal for advanced
Koepsell H
Expert Opin Drug Metab Toxicol; 2021 Jun; 17(6):635-653. PubMed ID: 33896325
[No Abstract] [Full Text] [Related]
33. Transcriptional regulation of murine Slc22a1 (Oct1) by peroxisome proliferator agonist receptor-alpha and -gamma.
Nie W; Sweetser S; Rinella M; Green RM
Am J Physiol Gastrointest Liver Physiol; 2005 Feb; 288(2):G207-12. PubMed ID: 15458920
[TBL] [Abstract][Full Text] [Related]
34. The two human organic cation transporter genes SLC22A1 and SLC22A2 are located on chromosome 6q26.
Koehler MR; Wissinger B; Gorboulev V; Koepsell H; Schmid M
Cytogenet Cell Genet; 1997; 79(3-4):198-200. PubMed ID: 9605850
[TBL] [Abstract][Full Text] [Related]
35. Pharmacological and physiological functions of the polyspecific organic cation transporters: OCT1, 2, and 3 (SLC22A1-3).
Jonker JW; Schinkel AH
J Pharmacol Exp Ther; 2004 Jan; 308(1):2-9. PubMed ID: 14576340
[TBL] [Abstract][Full Text] [Related]
36. Promoter hypomethylation up-regulates CD147 expression through increasing Sp1 binding and associates with poor prognosis in human hepatocellular carcinoma.
Kong LM; Liao CG; Chen L; Yang HS; Zhang SH; Zhang Z; Bian HJ; Xing JL; Chen ZN
J Cell Mol Med; 2011 Jun; 15(6):1415-28. PubMed ID: 20629990
[TBL] [Abstract][Full Text] [Related]
37. Cellular uptake properties of lamotrigine in human placental cell lines: Investigation of involvement of organic cation transporters (SLC22A1-5).
Hasegawa N; Furugen A; Ono K; Koishikawa M; Miyazawa Y; Nishimura A; Umazume T; Narumi K; Kobayashi M; Iseki K
Drug Metab Pharmacokinet; 2020 Jun; 35(3):266-273. PubMed ID: 32303459
[TBL] [Abstract][Full Text] [Related]
38. Pharmacokinetics of Organic Cation Transporter 1 (OCT1) Substrates in Oct1/2 Knockout Mice and Species Difference in Hepatic OCT1-Mediated Uptake.
Morse BL; Kolur A; Hudson LR; Hogan AT; Chen LH; Brackman RM; Sawada GA; Fallon JK; Smith PC; Hillgren KM
Drug Metab Dispos; 2020 Feb; 48(2):93-105. PubMed ID: 31771949
[TBL] [Abstract][Full Text] [Related]
39. DNA binding protein A expression and methylation status in hepatocellular carcinoma and the adjacent tissue.
Yasen M; Obulhasim G; Kajino K; Mogushi K; Mizushima H; Tanaka S; Tanaka H; Hino O; Arii S
Int J Oncol; 2012 Mar; 40(3):789-97. PubMed ID: 22159460
[TBL] [Abstract][Full Text] [Related]
40. Upregulation of DNMT1 mediated by HBx suppresses RASSF1A expression independent of DNA methylation.
Qiu X; Zhang L; Lu S; Song Y; Lao Y; Hu J; Fan H
Oncol Rep; 2014 Jan; 31(1):202-8. PubMed ID: 24247422
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
